Cargando...
How We Treat Febrile Neutropenia in Patients Receiving Cancer Chemotherapy
Although improved supportive care has reduced mortality associated with febrile neutropenia, it continues to cause chemotherapy limitations, morbidity, mortality, and cost among patients with cancer.
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society of Clinical Oncology
2010
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2868641/ https://ncbi.nlm.nih.gov/pubmed/20808559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.091092 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|